Medium materiality6/10
Opus Genetics (IRD) Reiterated at Market Outperform by Citizens: Focus on Viatris
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
CIZN target $12; current price $10.4; priceChangeSinceSignal -0.58; target reiterated by Nomura.
- Nomura reiterates Market Outperform on CIZN; target $12; price $10.40.
Key facts
- 01
Target: $12
- 02
Posted price: $10.4
- 03
Analyst firm: Nomura
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.